Cleared Traditional

K212143 - Neteera 130H/131H Vital Sign Monitoring Sensor (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2022
Decision
446d
Days
Class 2
Risk

K212143 is an FDA 510(k) clearance for the Neteera 130H/131H Vital Sign Monitoring Sensor. Classified as Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm) (product code DRT), Class II - Special Controls.

Submitted by Neteera Technologies , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on September 28, 2022 after a review of 446 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Neteera Technologies , Ltd. devices

Submission Details

510(k) Number K212143 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 09, 2021
Decision Date September 28, 2022
Days to Decision 446 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
321d slower than avg
Panel avg: 125d · This submission: 446d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code DRT Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. Clinical trial data may be submitted as supporting evidence to strengthen the substantial equivalence argument. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
Janice M. Hogan

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Clinical Evidence

ClinicalTrials.gov
NCT04796181 Completed Observational Industry-sponsored

Heart Rate and Respiratory Rate Measurements by a Novel, Radar-based Device

Single Center, Single Blinded, Prospective Validation Study for the Accuracy and Safety Evaluation of Neteera 130H, a Novel, Radar-based Contact-free Device for Heart and Respiratory Rate Measurements

170
Patients (actual)
2
Sites
Condition studied Healthy Subjects; Chronic Conditions, Multiple
Eligibility All sexes · 18 Years+ · Healthy volunteers accepted
Principal investigator Todd Bertoch, MD
Sponsor Neteera Technologies Ltd. (industry)
Started 2021-02-21 Primary completion 2022-03-25 Completed 2022-07-02
Primary outcome
Proportion of accurate spot HR while the Neteera 130H located behind the subject.
Secondary outcome
Repeating the primary endpoints in sitting position while the investigated device is located in front of the subject.
Study completed - no results published. This trial concluded in 2022 but has not posted results to ClinicalTrials.gov. Completed studies without public results are common in industry-sponsored device trials; the data may be referenced in the 510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov

Regulatory Peers - DRT Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm)

All 337
Devices cleared under the same product code (DRT) and FDA review panel - the closest regulatory comparables to K212143.
The Circadia C300 System (C300)
K252676 · Circadia Health, Inc. · Feb 2026
Sleepiz One+ (Model 2.5)
K253388 · Sleepiz AG · Jan 2026
Sleepiz One+ (2.5)
K251364 · Sleepiz AG · Jul 2025
The Circadia C200 System
K234003 · Circadia Technologies, Ltd. · May 2024
Vios Monitoring System(TM) Model 2050
K232354 · Murata Vios, Inc. · Mar 2024
Neteera 130H-Plus Vital Sign Monitoring Sensor
K231733 · Neteera Technologies , Ltd. · Feb 2024